Gene · 3595
Papers1,950
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,950
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis. | Front Med (Lausanne) | 2022 | 36530905 | PubTator, text mining | PubMed |
| Detailed phenotypic and functional characterization of CMV-associated adaptive NK cells in rhesus macaques. | Front Immunol | 2022 | 36518759 | PubTator, text mining | PubMed |
| A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid Leukemia. | Biomed Res Int | 2022 | 36518627 | PubTator, text mining | PubMed |
| Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy. | Front Med (Lausanne) | 2022 | 36507530 | PubTator, text mining | PubMed |
| Enrichment of T-cell proliferation and memory gene signatures of CD79A/CD40 costimulatory domain potentiates CD19CAR-T cell functions. | Front Immunol | 2022 | 36505428 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells. | Front Immunol | 2022 | 36466870 | PubTator, text mining | PubMed |
| The diagnostic value of interleukin 35 as a septic biomarker: A meta-analysis. | Front Med (Lausanne) | 2022 | 36438063 | PubTator, text mining | PubMed |
| The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy. | Cells | 2022 | 36429112 | PubTator, text mining | PubMed |
| Antitumor Activities of Interleukin-12 in Melanoma. | Cancers (Basel) | 2022 | 36428682 | PubTator, text mining | PubMed |
| Advances in the Lung Cancer Immunotherapy Approaches. | Vaccines (Basel) | 2022 | 36423060 | PubTator, text mining | PubMed |
| Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy. | Front Immunol | 2022 | 36405748 | PubTator, text mining | PubMed |
| Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis. | Ann Transl Med | 2022 | 36388802 | PubTator, text mining | PubMed |
| IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone. | Front Pharmacol | 2022 | 36386129 | PubTator, text mining | PubMed |
| Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing. | Front Genet | 2022 | 36338958 | PubTator, text mining | PubMed |
| Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. | Front Surg | 2022 | 36338652 | PubTator, text mining | PubMed |
| T-BET drives the conversion of human type 3 innate lymphoid cells into functional NK cells. | Front Immunol | 2022 | 36330517 | PubTator, text mining | PubMed |
| COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection. | PLoS Genet | 2022 | 36327221 | PubTator, text mining | PubMed |
| Suspected Pediatric-Onset Common Variable Immune Deficiency (CVID) in a Seven-Year-Old Female With Pulmonary Manifestations. | Cureus | 2022 | 36321039 | PubTator, text mining | PubMed |
| Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. | J Immunother Cancer | 2022 | 36319065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3595/papers?page=12